News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Evanson Jeff
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 04/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/24/2023 |
4
| Evanson Jeff (Chief Commercial Officer) has filed a Form 4 on Outlook Therapeutics, Inc.|
Txns:
| Sold 267,000 shares
@ $1.11, valued at
$296.4k
|
|
| 01/19/2023 |
4
| Evanson Jeff (Chief Commercial Officer) has filed a Form 4 on Outlook Therapeutics, Inc.|
Txns:
| Sold 27,162 shares
@ $1.31, valued at
$35.6k
Sold 33,738 shares
@ $1.25, valued at
$42.2k
Sold 103,255 shares
@ $1.22, valued at
$126k
|
|
| 04/04/2022 |
4
| Evanson Jeff (Chief Commercial Officer) has filed a Form 4 on Outlook Therapeutics, Inc.|
Txns:
| Granted 100,000 options to buy
@ $1.44, valued at
$144k
|
|
| 12/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/25/2021 |
4
| Evanson Jeff (Chief Commercial Officer) has filed a Form 4 on Outlook Therapeutics, Inc.|
Txns:
| Sold 8,554 shares
@ $2.088, valued at
$17.9k
|
|
| 02/17/2021 |
4
| Evanson Jeff (Chief Commercial Officer) has filed a Form 4 on Outlook Therapeutics, Inc.|
Txns:
| Sold 56,973 shares
@ $2.55, valued at
$145.3k
|
|
| 04/21/2020 |
4
| Evanson Jeff (Chief Commercial Officer) has filed a Form 4 on Outlook Therapeutics, Inc.|
Txns:
| Granted 1,207,457 shares
@ $0 |
|
| 12/04/2018 |
3
| Evanson Jeff (Chief Commercial Officer) has filed a Form 3 on Outlook Therapeutics, Inc. |
|
|